The effect of sex hormones on bone metabolism of the otic capsule - an overview

Hearing Research

Volumn 252, Issue 1-2, 2009, Pages 56-60

  Horner, Kathleen C ^a  

^a University of Mediterranée   (France)

Author keywords

Bone; Cochlea; Estrogen; Hormones; Osteoprotegerin; Prolactin; RANK

Indexed keywords

CALCIUM; ESTROGEN; FOLLITROPIN; GESTAGEN; NEUROLEPTIC AGENT; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROLACTIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SEX HORMONE;

AGING; APOPTOSIS; ARTICLE; AUDITORY OSSICLE; BONE DENSITY; BONE METABOLISM; CALCIUM METABOLISM; CELL ACTIVATION; CELL LINEAGE; CELL MATURATION; COCHLEA; CONTROL SYSTEM; DISEASE ASSOCIATION; DRUG POTENTIATION; HEARING LOSS; HORMONAL REGULATION; HORMONE SUBSTITUTION; HUMAN; HYPERPROLACTINEMIA; INNER EAR DISEASE; LACTATION; MENOPAUSE; MULTIPLE PREGNANCY; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; OSTEOSCLEROSIS; PRIORITY JOURNAL; PROLACTIN RELEASE; PROTEIN PROTEIN INTERACTION; SINGLE DRUG DOSE; VESTIBULAR DISORDER;

ANIMALS; BONE AND BONES; BONE DISEASES; EAR, INNER; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; HEARING LOSS; HUMANS; MICE; OSTEOPOROSIS; OTOSCLEROSIS; PREGNANCY; PROLACTIN; RANK LIGAND;

EID: 67349241668     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.heares.2008.12.004     Document Type: Article

References (91)

1. Allali F., Maaroufi H., Aichaoui S.E., Khazani H., Saoud B., Benyahya B., Abouqal R., and Hajjaj-Hassouni N. Influence of parity on bone mineral density and peripheral fracture risk in Moroccan postmenopausal women. Maturitas 57 (2007) 392-398
2. Al-Mana D., Ceranic B., Djahanbakhch O., and Luxon L.M. Hormones and the auditory system: a review of physiology and pathophysiology. Neuroscience 153 (2008) 881-900
3. Amendt P., Hesse V., and Rohde W. Somatomedin-C/IGF-I, insulin and prolactin levels in Ullrich-Turner's syndrome. Exp. Clin. Endocrinol. 99 (1992) 73-76
4. Arbogast L.A., and Ben-Jonathan N. The preovulatory prolactin surge is prolonged by a progesterone-dependent dopaminergic mechanism. Endocrinology 126 (1990) 246-252
5. In: Arnold W. (Ed). Advances in Oto-Rhino-Laryngology vol. 65 (2007), Otosclerosis and Stapes Surgery, Karger, Basel
6. Arnold W., Niedermeyer H.P., Altermatt H.J., and Neubert W.J. Pathogenesis of otosclerosis. "State of the art". Hno 44 (1996) 121-129
7. Baranowska B., Wolinska-Witort E., Bik W., Baranowska-Bik A., Martynska L., Chmielowska M., Broczek K., and Mossakowska M. Evaluation of neuroendocrine status in longevity. Neurobiol. Aging 28 (2007) 774-783
8. Baron R. FSH versus estrogen: who's guilty of breaking bones?. Cell Metab. 3 (2006) 302-305
9. Bekker P.J., Holloway D., Nakanishi A., Arrighi M., Leese P.T., and Dunstan C.R. The effect of a single dose of osteoprotegerin in postmenopausal women. J. Bone Miner. Res. 16 (2001) 348-360
10. Blackman M.R., Kowatch M.A., Wehmann R.E., and Harman S.M. Basal serum prolactin levels and prolactin responses to constant infusions of thyrotropin releasing hormone in healthy aging men. J. Gerontol. 41 (1986) 699-705
11. Boyle W.J., Simonet W.S., and Lacey D.L. Osteoclast differentiation and activation. Nature 423 (2003) 337-342
12. Bucay N., Sarosi I., Dunstan C.R., Morony S., Tarpley J., Capparelli C., Scully S., Tan H.L., Xu W., Lacey D.L., Boyle W.J., and Simonet W.S. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12 (1998) 1260-1268
13. Buzi F., Maccarinelli G., Guaragni B., Ruggeri F., Radetti G., Meini A., Mazzolari E., and Cocchi D. Serum osteoprotegerin and receptor activator of nuclear factors kB (RANKL) concentrations in normal children and in children with pubertal precocity, Turner's syndrome and rheumatoid arthritis. Clin. Endocrinol. (Oxf) 60 (2004) 87-91
14. Caligaris L., Astrada J.J., and Taleisnik S. Oestrogen and progesterone influence on the release of prolactin in ovariectomized rats. J. Endocrinol. 60 (1974) 205-215
15. Caruso S., Maiolino L., Rugolo S., Intelisano G., Farina M., Cocuzza S., and Serra A. Auditory brainstem response in premenopausal women taking oral contraceptives. Hum. Reprod. 18 (2003) 85-89
16. Charoenphandhu N., and Krishnamra N. Prolactin is an important regulator of intestinal calcium transport. Can. J. Physiol. Pharmacol. 85 (2007) 569-581
17. Charoenphandhu N., Teerapornpuntakit J., Methawasin M., Wongdee K., Thongchote K., and Krishnamra N. Prolactin decreases expression of Runx2, osteoprotegerin, and RANKL in primary osteoblasts derived from tibiae of adult female rats. Can. J. Physiol. Pharmacol. 86 (2008) 240-248
18. Chole R.A., and McKenna M. Pathophysiology of otosclerosis. Otol. Neurotol. 22 (2001) 249-257
19. Clark K., Sowers M.R., Wallace R.B., Jannausch M.L., Lemke J., and Anderson C.V. Age-related hearing loss and bone mass in a population of rural women aged 60 to 85 years. Ann. Epidemiol. 5 (1995) 8-14
20. Clayton A.E., Mikulec A.A., Mikulec K.H., Merchant S.N., and McKenna M.J. Association between osteoporosis and otosclerosis in women. J. Laryngol. Otol. 118 (2004) 617-621
21. Coss D., Yang L., Kuo C.B., Xu X., Luben R.A., and Walker A.M. Effects of prolactin on osteoblast alkaline phosphatase and bone formation in the developing rat. Am. J. Physiol. Endocrinol. Metab. 279 (2000) E1216-E1225
22. Darlington C.L., Ross A., King J., and Smith P.F. Menstrual cycle effects on postural stability but not optokinetic function. Neurosci. Lett. 307 (2001) 147-150
23. Dougall W.C., Glaccum M., Charrier K., Rohrbach K., Brasel K., De Smedt T., Daro E., Smith J., Tometsko M.E., Maliszewski C.R., Armstrong A., Shen V., Bain S., Cosman D., Anderson D., Morrissey P.J., Peschon J.J., and Schuh J. RANK is essential for osteoclast and lymph node development. Genes Dev. 13 (1999) 2412-2424
24. Elkind-Hirsch K.E., Stoner W.R., Stach B.A., and Jerger J.F. Estrogen influences auditory brainstem responses during the normal menstrual cycle. Hear. Res. 60 (1992) 143-148
25. Elkind-Hirsch K.E., Wallace E., Stach B.A., and Jerger J.F. Cyclic steroid replacement alters auditory brainstem responses in young women with premature ovarian failure. Hear. Res. 64 (1992) 93-98
26. Falkenius-Schmidt K., Rydmarker S., and Horner K.C. Hyperprolactinemia in some Meniere patients even in the absence of incapacitating vertigo. Hear. Res. 203 (2005) 154-158
27. Gordon-Salant S. Hearing loss and aging: new research findings and clinical implications. J. Rehabil. Res. Dev. 42 (2005) 9-24
28. Gristwood R.E., and Venables W.N. Pregnancy and otosclerosis. Clin. Otolaryngol. Allied Sci. 8 (1983) 205-210
29. Guimaraes P., Frisina S.T., Mapes F., Tadros S.F., Frisina D.R., and Frisina R.D. Progestin negatively affects hearing in aged women. Proc. Natl. Acad. Sci. USA 103 (2006) 14246-14249
30. Hanna G.S. Sudden deafness and the contraceptive pill. J. Laryngol. Otol. 100 (1986) 701-706
31. Helzner E.P., Cauley J.A., Pratt S.R., Wisniewski S.R., Talbott E.O., Zmuda J.M., Harris T.B., Rubin S.M., Taaffe D.R., Tylavsky F.A., and Newman A.B. Hearing sensitivity and bone mineral density in older adults: the health, aging and body composition study. Osteoporos. Int. 16 (2005) 1675-1682
32. Hofbauer L.C., Khosla S., Dunstan C.R., Lacey D.L., Spelsberg T.C., and Riggs B.L. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology 140 (1999) 4367-4370
33. Hofbauer L.C., and Schoppet M. Serum measurement of osteoprotegerin-clinical relevance and potential applications. Eur. J. Endocrinol. 145 (2001) 681-683
34. Horner K.C. The emotional ear in stress. Neurosci. Biobehav. Rev. 27 (2003) 437-446
35. Horner K.C., Cazals Y., Guieu R., Lenoir M., and Sauze N. Experimental estrogen-induced hyperprolactinemia results in bone-related hearing loss in the guinea pig. Am. J. Physiol. Endocrinol. Metab. 293 (2007) E1224-E1232
36. Horner K.C., Guieu R., Magnan J., Chays A., and Cazals Y. Prolactinoma in some Meniere's patients-is stress involved?. Neuropsychopharmacology 26 (2002) 135-138
37. Huizing E.H., and de Groot J.A. Densitometry of the cochlear capsule and correlation between bone density loss and bone conduction hearing loss in otosclerosis. Acta Otolaryngol. 103 (1987) 464-468
38. Hultcrantz M., Simonoska R., and Stenberg A.E. Estrogen and hearing: a summary of recent investigations. Acta Otolaryngol. 126 (2006) 10-14
39. Iotsova V., Caamano J., Loy J., Yang Y., Lewin A., and Bravo R. Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat. Med. 3 (1997) 1285-1289
40. Kameda T., Mano H., Yuasa T., Mori Y., Miyazawa K., Shiokawa M., Nakamaru Y., Hiroi E., Hiura K., Kameda A., Yang N.N., Hakeda Y., and Kumegawa M. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J. Exp. Med. 186 (1997) 489-495
41. Kanzaki S., Ito M., Takada Y., Ogawa K., and Matsuo K. Resorption of auditory ossicles and hearing loss in mice lacking osteoprotegerin. Bone 39 (2006) 414-419
42. Karosi T., Jokay I., Konya J., Szabo L.Z., Pytel J., Jori J., Szalmas A., and Sziklai I. Detection of osteoprotegerin and TNF-alpha mRNA in ankylotic stapes footplates in connection with measles virus positivity. Laryngoscope 116 (2006) 1427-1433
43. Kilicdag E.B., Yavuz H., Bagis T., Tarim E., Erkan A.N., and Kazanci F. Effects of estrogen therapy on hearing in postmenopausal women. Am. J. Obstet. Gynecol. 190 (2004) 77-82
44. Kim S.H., Kang B.M., Chae H.D., and Kim C.H. The association between serum estradiol level and hearing sensitivity in postmenopausal women. Obstet. Gynecol. 99 (2002) 726-730
45. Kong Y.Y., Yoshida H., Sarosi I., Tan H.L., Timms E., Capparelli C., Morony S., Oliveira-dos-Santos A.J., Van G., Itie A., Khoo W., Wakeham A., Dunstan C.R., Lacey D.L., Mak T.W., Boyle W.J., and Penninger J.M. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397 (1999) 315-323
46. Kopp P., Pesce L., and Solis S.J. Pendred syndrome and iodide transport in the thyroid. Trends Endocrinol. Metab. 19 (2008) 260-268
47. Kovacs C.S. Calcium and bone metabolism during pregnancy and lactation. J. Mammary Gland Biol. Neoplasia 10 (2005) 105-118
48. Li J., Sarosi I., Yan X.Q., Morony S., Capparelli C., Tan H.L., McCabe S., Elliott R., Scully S., Van G., Kaufman S., Juan S.C., Sun Y., Tarpley J., Martin L., Christensen K., McCabe J., Kostenuik P., Hsu H., Fletcher F., Dunstan C.R., Lacey D.L., and Boyle W.J. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl. Acad. Sci. USA 97 (2000) 1566-1571
49. Lippy W.H., Berenholz L.P., Schuring A.G., and Burkey J.M. Does pregnancy affect otosclerosis?. Laryngoscope 115 (2005) 1833-1836
50. McFadden D. Masculinizing effects on otoacoustic emissions and auditory evoked potentials in women using oral contraceptives. Hear. Res. 142 (2000) 23-33
51. McKenna M.J., and Kristiansen A.G. Molecular biology of otosclerosis. Adv. Otorhinolaryngol. 65 (2007) 68-74
52. McKenna M.J., Nguyen-Huynh A.T., and Kristiansen A.G. Association of otosclerosis with Sp1 binding site polymorphism in COL1A1 gene: evidence for a shared genetic etiology with osteoporosis. Otol. Neurotol. 25 (2004) 447-450
53. Meltser I., Tahera Y., Simpson E., Hultcrantz M., Charitidi K., Gustafsson J.A., and Canlon B. Estrogen receptor beta protects against acoustic trauma in mice. J. Clin. Invest. 118 (2008) 1563-1570
54. Metka M., Holzer G., Raimann H., Heytmanek G., Hartmann B., and Kurz C. The role of prolactin in the menopause. Maturitas 20 (1994) 151-154
55. Mitre E.I., Figueira A.S., Rocha A.B., and Alves S.M. Audiometric and vestibular evaluation in women using the hormonal contraceptive method. Rev. Bras. Otorrinolaringol. (Engl. Ed.) 72 (2006) 350-354
56. Mizuno A., Amizuka N., Irie K., Murakami A., Fujise N., Kanno T., Sato Y., Nakagawa N., Yasuda H., Mochizuki S., Gomibuchi T., Yano K., Shima N., Washida N., Tsuda E., Morinaga T., Higashio K., and Ozawa H. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem. Biophys. Res. Commun. 247 (1998) 610-615
57. Murphy M.P., and Gates G.A. Hearing loss: does gender play a role?. Med. Womens Health 2 (1997) 2
58. Niedermeyer H.P., and Arnold W. Otosclerosis and measles virus - association or causation?. ORL J. Otorhinolaryngol. Relat. Spec. 70 (2008) 63-69 (discussion 69-70)
59. Okulicz G. Inner ear disturbance following long-term usage of hormonal contraceptives (author's transl). Hno 26 (1978) 330-334
60. Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J. Bone Miner. Res. 11 (1996) 1043-1051
61. Paparella M.M., Mancini F., and Liston S.L. Otosclerosis and Meniere's syndrome: diagnosis and treatment. Laryngoscope 94 (1984) 1414-1417
62. Pearson J.D., Morrell C.H., Gordon-Salant S., Brant L.J., Metter E.J., Klein L.L., and Fozard J.L. Gender differences in a longitudinal study of age-associated hearing loss. J. Acoust. Soc. Am. 97 (1995) 1196-1205
63. Pecins-Thompson M., and Bethea C.L. RU 486 blocks and fluoxetine augments progesterone-induced prolactin secretion in monkeys. Neuroendocrinology 65 (1997) 335-343
64. Peveler R.C., Branford D., Citrome L., Fitzgerald P., Harvey P.W., Holt R.I., Howard L., Kohen D., Jones I., O'Keane V., Pariente C.M., Pendlebury J., Smith S.M., and Yeomans D. Antipsychotics and hyperprolactinaemia: clinical recommendations. J. Psychopharmacol. 22 (2008) 98-103
65. Pinilla L., Gonzalez L.C., Tena-Sempere M., and Aguilar E. Evidence for an estrogen-like action of raloxifene upon the hypothalamic-pituitary unit: raloxifene inhibits luteinizing hormone secretion and stimulates prolactin secretion in ovariectomized female rats. Neurosci. Lett. 311 (2001) 149-152
66. Raymond V., Beaulieu M., Labrie F., and Boissier J. Potent antidopaminergic activity of estradiol at the pituitary level on prolactin release. Science 200 (1978) 1173-1175
67. Riggs B.L. Endocrine causes of age-related bone loss and osteoporosis. Novartis Found Symp. 242 (2002) 247-259 (discussion 260-4)
68. Rillema J.A., and Hill M.A. Prolactin regulation of the pendrin-iodide transporter in the mammary gland. Am. J. Physiol. Endocrinol. Metab. 284 (2003) E25-E28
69. Royaux I.E., Belyantseva I.A., Wu T., Kachar B., Everett L.A., Marcus D.C., and Green E.D. Localization and functional studies of pendrin in the mouse inner ear provide insight about the etiology of deafness in pendred syndrome. J. Assoc. Res. Otolaryngol. 4 (2003) 394-404
70. Rybak L.P. Metabolic disorders of the vestibular system. Otolaryngol. Head Neck Surg. 112 (1995) 128-132
71. Sato S., Hanew K., Sasaki A., Shimizu Y., Murakami O., Fukazawa H., Sakurada T., Saito S., and Yoshinaga K. Enhanced prolactin secretion in patients with primary hypothyroidism during thyroid replacement. Tohoku J. Exp. Med. 144 (1984) 425-431
72. Schwarz E.M., and Ritchlin C.T. Clinical development of anti-RANKL therapy. Arthritis Res. Ther. 9 Suppl. 1 (2007) S7
73. Seemungal B.M., Gresty M.A., and Bronstein A.M. The endocrine system, vertigo and balance. Curr. Opin. Neurol. 14 (2001) 27-34
74. Sellari-Franceschini S., Ravecca F., De Vito A., and Berrettini S. Progressive sensorineural hearing loss in cochlear otosclerosis. Acta Otorhinolaryngol. Ital. 18 (1998) 59-65
75. Sennaroglu G., and Belgin E. Audiological findings in pregnancy. J. Laryngol. Otol. 115 (2001) 617-621
76. Seriwatanachai D., Charoenphandhu N., Suthiphongchai T., and Krishnamra N. Prolactin decreases the expression ratio of receptor activator of nuclear factor kappaB ligand/osteoprotegerin in human fetal osteoblast cells. Cell Biol. Int. 32 (2008) 1126-1135
77. Seriwatanachai D., Thongchote K., Charoenphandhu N., Pandaranandaka J., Tudpor K., Teerapornpuntakit J., Suthiphongchai T., and Krishnamra N. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio. Bone 42 (2008) 535-546
78. Serra A., Maiolino L., Agnello C., Messina A., and Caruso S. Auditory brain stem response throughout the menstrual cycle. Ann. Otol. Rhinol. Laryngol. 112 (2003) 549-553
79. Shea Jr. J.J., Ge X., and Orchik D.J. Endolymphatic hydrops associated with otosclerosis. Am. J. Otol. 15 (1994) 348-357
80. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R., Nguyen H.Q., Wooden S., Bennett L., Boone T., Shimamoto G., DeRose M., Elliott R., Colombero A., Tan H.L., Trail G., Sullivan J., Davy E., Bucay N., Renshaw-Gegg L., Hughes T.M., Hill D., Pattison W., Campbell P., Sander S., Van G., Tarpley J., Derby P., Lee R., and Boyle W.J. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89 (1997) 309-319
81. Sismanis A., Hughes G.B., and Abedi E. Coexisting otosclerosis and Meniere's disease: a diagnostic and therapeutic dilemma. Laryngoscope 96 (1986) 9-13
82. Srivastava S., Toraldo G., Weitzmann M.N., Cenci S., Ross F.P., and Pacifici R. Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation. J. Biol. Chem. 276 (2001) 8836-8840
83. Strachan D. Sudden sensorineural deafness and hormone replacement therapy. J. Laryngol. Otol. 110 (1996) 1148-1150
84. Sun L., Peng Y., Sharrow A.C., Iqbal J., Zhang Z., Papachristou D.J., Zaidi S., Zhu L.L., Yaroslavskiy B.B., Zhou H., Zallone A., Sairam M.R., Kumar T.R., Bo W., Braun J., Cardoso-Landa L., Schaffler M.B., Moonga B.S., Blair H.C., and Zaidi M. FSH directly regulates bone mass. Cell 125 (2006) 247-260
85. Swanson S.J., and Dengerink H.A. Changes in pure-tone thresholds and temporary threshold shifts as a function of menstrual cycle and oral contraceptives. J. Speech Hear. Res. 31 (1988) 569-574
86. Tsunoda K., Takahashi S., Takanosawa M., and Shimoji Y. The influence of pregnancy on sensation of ear problems-ear problems associated with healthy pregnancy. J. Laryngol. Otol. 113 (1999) 318-320
87. Vessey M., and Painter R. Oral contraception and ear disease: findings in a large cohort study. Contraception 63 (2001) 61-63
88. Williams R.F., Gianfortoni J.G., and Hodgen G.D. Hyperprolactinemia induced by an estrogen-progesterone synergy: quantitative and temporal effects of estrogen priming in monkeys. J. Clin. Endocrinol. Metab. 60 (1985) 126-132
89. Yoon T.H., Paparella M.M., and Schachern P.A. Otosclerosis involving the vestibular aqueduct and Meniere's disease. Otolaryngol. Head Neck Surg. 103 (1990) 107-112
90. Zehnder A.F., Kristiansen A.G., Adams J.C., Kujawa S.G., Merchant S.N., and McKenna M.J. Osteoprotegrin knockout mice demonstrate abnormal remodeling of the otic capsule and progressive hearing loss. Laryngoscope 116 (2006) 201-206
91. Zehnder A.F., Kristiansen A.G., Adams J.C., Merchant S.N., and McKenna M.J. Osteoprotegerin in the inner ear may inhibit bone remodeling in the otic capsule. Laryngoscope 115 (2005) 172-177